Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC.
| Image |  |
|---|---|
| Description | scientific article published on 27 February 2014 |
| Author/s |
author: Stephen Clarke Alexander Dobrovic |
| Publication date | February 27, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |